| 51 | 24985178 | [Effect of bromdomain protein 4 inhibitor GSK525762A on the proliferation and apoptosis of B-cell acute lymphoblastic leukemia cells and its mechanism]. | Zhonghua Xue Ye Xue Za Zhi | 2014 Jun |
4 |
| 52 | 25097667 | Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching. | Epigenetics Chromatin | 2014 |
2 |
| 53 | 25120803 | Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder. | Int J Clin Exp Pathol | 2014 |
1 |
| 54 | 25290579 | Fluorinated aromatic amino acids are sensitive 19F NMR probes for bromodomain-ligand interactions. | ACS Chem Biol | 2014 Dec 19 |
3 |
| 55 | 25338565 | [Effect of BRD4 inhibitor GSK525762A on proliferation and apoptosis of KU812 leukemic cells and its mechanism]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2014 Oct |
3 |
| 56 | 25340539 | Phosphorylation of HPV-16 E2 at serine 243 enables binding to Brd4 and mitotic chromosomes. | PLoS One | 2014 |
4 |
| 57 | 25537515 | Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers. | Oncotarget | 2015 Feb 10 |
1 |
| 58 | 25559428 | Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimization. | J Med Chem | 2015 Feb 12 |
2 |
| 59 | 25603177 | BRD4 inhibitor inhibits colorectal cancer growth and metastasis. | Int J Mol Sci | 2015 Jan 16 |
1 |
| 60 | 25647019 | BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance. | Oncol Rep | 2015 Apr |
4 |
| 61 | 25678016 | Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors. | Bioorg Med Chem | 2015 Mar 1 |
4 |
| 62 | 25703523 | 9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain. | J Med Chem | 2015 Mar 26 |
1 |
| 63 | 25788266 | H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription. | Oncotarget | 2015 Mar 30 |
1 |
| 64 | 25941994 | Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. | Epigenetics | 2015 |
2 |
| 65 | 25944566 | BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells. | Sci Rep | 2015 May 6 |
1 |
| 66 | 25946208 | A Genetically Encoded FRET Probe to Detect Intranucleosomal Histone H3K9 or H3K14 Acetylation Using BRD4, a BET Family Member. | ACS Chem Biol | 2016 Mar 18 |
1 |
| 67 | 26045013 | Phthalimide-Conjugated Ligands Promote Selective Protein Destabilization. | Cancer Discov | 2015 Jul |
1 |
| 68 | 26083714 | Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism. | Elife | 2015 Jun 17 |
1 |
| 69 | 26119939 | Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors. | Oncogene | 2016 Apr 7 |
1 |
| 70 | 26158404 | Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules. | ACS Chem Biol | 2015 Oct 16 |
1 |
| 71 | 26191363 | BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536. | ACS Med Chem Lett | 2015 Jul 9 |
11 |
| 72 | 26224795 | Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension. | Circ Res | 2015 Aug 28 |
3 |
| 73 | 26304078 | [In vitro study of BRD4 inhibitor GSK525762A against primary adult common B-cell acute lymphoblastic leukemia cells in vitro]. | Zhonghua Xue Ye Xue Za Zhi | 2015 Jul |
3 |
| 74 | 26416749 | Mediator kinase inhibition further activates super-enhancer-associated genes in AML. | Nature | 2015 Oct 8 |
1 |
| 75 | 26456956 | Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma. | Tumour Biol | 2016 Mar |
2 |
| 76 | 26504077 | Kinetically Defined Mechanisms and Positions of Action of Two New Modulators of Glucocorticoid Receptor-regulated Gene Induction. | J Biol Chem | 2016 Jan 1 |
2 |
| 77 | 26536665 | Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth. | Oncotarget | 2016 Feb 9 |
1 |
| 78 | 26546038 | High-density P300 enhancers control cell state transitions. | BMC Genomics | 2015 Nov 6 |
1 |
| 79 | 26707881 | Inhibition of BRD4 suppresses tumor growth and enhances iodine uptake in thyroid cancer. | Biochem Biophys Res Commun | 2016 Jan 15 |
2 |
| 80 | 26731611 | 4-Acyl Pyrrole Derivatives Yield Novel Vectors for Designing Inhibitors of the Acetyl-Lysine Recognition Site of BRD4(1). | J Med Chem | 2016 Feb 25 |
3 |
| 81 | 26735842 | Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins. | J Med Chem | 2016 Feb 25 |
2 |
| 82 | 26878240 | 7SK-BAF axis controls pervasive transcription at enhancers. | Nat Struct Mol Biol | 2016 Mar |
1 |
| 83 | 26976114 | Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628. | Cancer Discov | 2016 May |
1 |
| 84 | 26983878 | Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells. | Mol Cancer Ther | 2016 Jun |
1 |
| 85 | 26985285 | Dihydropteridinone Inhibitors of BRD4. | ACS Med Chem Lett | 2016 Feb 11 |
1 |
| 86 | 27007123 | The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC. | J Neurovirol | 2016 Oct |
1 |
| 87 | 27063978 | Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study. | Lancet Haematol | 2016 Apr |
1 |
| 88 | 27142751 | Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors. | Bioorg Med Chem Lett | 2016 Jun 15 |
1 |
| 89 | 27148573 | Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case. | Cold Spring Harb Mol Case Stud | 2015 Oct |
2 |
| 90 | 27219867 | Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains. | J Med Chem | 2016 Jun 9 |
1 |
| 91 | 27238211 | NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds. | Acta Pharmacol Sin | 2016 Jul |
3 |
| 92 | 27264992 | Isoxazole-Derived Amino Acids are Bromodomain-Binding Acetyl-Lysine Mimics: Incorporation into Histone H4 Peptides and Histone H3. | Angew Chem Int Ed Engl | 2016 Jul 11 |
8 |
| 93 | 27266999 | Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitors. | Eur J Med Chem | 2016 Oct 4 |
2 |
| 94 | 27290915 | An Overview on Small Molecule Inhibitors of BRD4. | Mini Rev Med Chem | 2016 |
4 |
| 95 | 27425608 | Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA. | Cell Rep | 2016 Aug 2 |
1 |
| 96 | 27494802 | Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors. | J Biomol Struct Dyn | 2017 Aug |
6 |
| 97 | 27496136 | Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma. | Mol Cancer Ther | 2016 Nov |
9 |
| 98 | 27520485 | Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1. | Biochem Pharmacol | 2016 Oct 1 |
1 |
| 99 | 27573426 | AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies. | Mol Cancer Ther | 2016 Nov |
4 |
| 100 | 27580186 | Design, synthesis and biological evaluation of dihydroquinoxalinone derivatives as BRD4 inhibitors. | Bioorg Chem | 2016 Oct |
3 |